Selective blood-brain barrier permeabilization of brain metastases by a type 1 receptor-selective tumor necrosis factor mutein. (2022)
Attributed to:
Permeabilisation of brain metastases for early and more effective treatment
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/neuonc/noab177
PubMed Identifier: 34297105
Publication URI: http://europepmc.org/abstract/MED/34297105
Type: Journal Article/Review
Volume: 24
Parent Publication: Neuro-oncology
Issue: 1
ISSN: 1522-8517